Skip to main content
Top
Published in: Infection 6/2018

01-12-2018 | Brief Report

Clinical and microbiological characteristics of adult invasive Haemophilus influenzae infections: results of a 14-year single-center experience from Hungary

Authors: Balint Gergely Szabo, Katalin Szidonia Lenart, Tamas Tirczka, Eszter Ostorhazi

Published in: Infection | Issue 6/2018

Login to get access

Abstract

To describe the characteristics of adult invasive H. influenzae disease, 34 patients diagnosed at a single tertiary center between 2004 and 2017 were analyzed in a retrospective case series study. The annual estimated incidence was 0.1 cases/100.000 inhabitants. Dominant source of infection was pneumonia accompanied by sepsis (62%) and caused by nontypeable strains (74%) with low ampicillin resistance (14%). Survival (94%) and complication rates were high (35%). Main empirical treatments were ceftriaxone or levofloxacine.
Literature
2.
go back to reference Shimol SB, Dagan R. Haemophilus influenzae: still a relevant invasive pathogen. Isr Med Assoc J. 2012;14:432–4.PubMed Shimol SB, Dagan R. Haemophilus influenzae: still a relevant invasive pathogen. Isr Med Assoc J. 2012;14:432–4.PubMed
3.
go back to reference Falla T, Crook D, Brophy L, Maskell D, Kroll J, Moxon E. PCR for capsular typing of Haemophilus influenzae. J Clin Microbiol. 1994;32:2382–6.PubMedPubMedCentral Falla T, Crook D, Brophy L, Maskell D, Kroll J, Moxon E. PCR for capsular typing of Haemophilus influenzae. J Clin Microbiol. 1994;32:2382–6.PubMedPubMedCentral
5.
go back to reference Ladhani S, Slack MP, Heath PT, Von Gottberg A, Chandra M, Ramsay ME, et al. Invasive Haemophilus influenzae disease, Europe, 1996–2006. Emerg Infect Dis. 2010;16:455–63.CrossRef Ladhani S, Slack MP, Heath PT, Von Gottberg A, Chandra M, Ramsay ME, et al. Invasive Haemophilus influenzae disease, Europe, 1996–2006. Emerg Infect Dis. 2010;16:455–63.CrossRef
6.
go back to reference Whittaker R, Economopoulou A, Dias JG, Bancroft E, Ramliden M, Celentano LP. Epidemiology of invasive Haemophilus influenzae disease, Europe, 2007–2014. Emerg Infect Dis. 2017;23:396–404.CrossRef Whittaker R, Economopoulou A, Dias JG, Bancroft E, Ramliden M, Celentano LP. Epidemiology of invasive Haemophilus influenzae disease, Europe, 2007–2014. Emerg Infect Dis. 2017;23:396–404.CrossRef
7.
go back to reference MacNeil JR, Cohn AC, Farley M, Mair R, Baumbach J, Bennett N, et al. Current epidemiology and trends in invasive Haemophilus influenzae disease—United States, 1989–2008. Clin Infect Dis. 2011;53:1230–6.CrossRef MacNeil JR, Cohn AC, Farley M, Mair R, Baumbach J, Bennett N, et al. Current epidemiology and trends in invasive Haemophilus influenzae disease—United States, 1989–2008. Clin Infect Dis. 2011;53:1230–6.CrossRef
8.
go back to reference Puig C, Grau I, Marti S, Tubau F, Calatayud L, Pallares R, et al. Clinical and molecular epidemiology of Haemophilus influenzae causing invasive disease in adult patients. PLoS One. 2014;9:1–7. Puig C, Grau I, Marti S, Tubau F, Calatayud L, Pallares R, et al. Clinical and molecular epidemiology of Haemophilus influenzae causing invasive disease in adult patients. PLoS One. 2014;9:1–7.
9.
go back to reference Blain A, MacNeil J, Wang X, Bennett N, Farley M, Harrison LH, et al. Invasive Haemophilus influenzae disease in adults ≥ 65 years, United States, 2011. Open Forum Infect Dis. 2014;1:ofu044.CrossRef Blain A, MacNeil J, Wang X, Bennett N, Farley M, Harrison LH, et al. Invasive Haemophilus influenzae disease in adults ≥ 65 years, United States, 2011. Open Forum Infect Dis. 2014;1:ofu044.CrossRef
10.
go back to reference Kiliç H, Akyol S, Parkan ÕM, Dinç G, Sav H, Aydemir G. Molecular characterization and antibiotic susceptibility of Haemophilus influenzae clinical isolates. Inf Med. 2017;25:27–32. Kiliç H, Akyol S, Parkan ÕM, Dinç G, Sav H, Aydemir G. Molecular characterization and antibiotic susceptibility of Haemophilus influenzae clinical isolates. Inf Med. 2017;25:27–32.
11.
go back to reference Bae S, Lee J, Lee J, Kim E, Lee S, Yu J, et al. Antimicrobial resistance in Haemophilus influenzae respiratory tract isolates in Korea: results of a nationwide acute respiratory infections surveillance. Antimicrob Agents Chemother. 2010;54:65–71.CrossRef Bae S, Lee J, Lee J, Kim E, Lee S, Yu J, et al. Antimicrobial resistance in Haemophilus influenzae respiratory tract isolates in Korea: results of a nationwide acute respiratory infections surveillance. Antimicrob Agents Chemother. 2010;54:65–71.CrossRef
13.
go back to reference Van Wessel K, Rodenburg GD, Veenhoven RH, Spanjaard L, Van Der Ende A, Sanders EAM. Nontypeable Haemophilus influenzae invasive disease in the Netherlands: a retrospective surveillance study 2001–2008. Clin Infect Dis. 2011;53:8–12. Van Wessel K, Rodenburg GD, Veenhoven RH, Spanjaard L, Van Der Ende A, Sanders EAM. Nontypeable Haemophilus influenzae invasive disease in the Netherlands: a retrospective surveillance study 2001–2008. Clin Infect Dis. 2011;53:8–12.
14.
go back to reference Laupland KB, Schønheyder HC, Østergaard C, Knudsen JD, Valiquette L, Galbraith J, et al. Epidemiology of Haemophilus influenzae Bacteremia: a multi-national population-based assessment. J Infect. 2011;62:142–8.CrossRef Laupland KB, Schønheyder HC, Østergaard C, Knudsen JD, Valiquette L, Galbraith J, et al. Epidemiology of Haemophilus influenzae Bacteremia: a multi-national population-based assessment. J Infect. 2011;62:142–8.CrossRef
Metadata
Title
Clinical and microbiological characteristics of adult invasive Haemophilus influenzae infections: results of a 14-year single-center experience from Hungary
Authors
Balint Gergely Szabo
Katalin Szidonia Lenart
Tamas Tirczka
Eszter Ostorhazi
Publication date
01-12-2018
Publisher
Springer Berlin Heidelberg
Published in
Infection / Issue 6/2018
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-018-1213-6

Other articles of this Issue 6/2018

Infection 6/2018 Go to the issue

Images in Infection

Cutaneous mucormycosis

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.